Diabetes, Vol 49, Issue 10 1740-1743, Copyright © 2000 by American Diabetes Association

ARTICLES

Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes

M Kossila, M Sinkovic, P Karkkainen, MO Laukkanen, R Miettinen, J Rissanen, P Kekalainen, J Kuusisto, S Yla-Herttuala and M Laakso
A.I. Virtanen Institute, University of Kuopio, Finland.

Phosphatidylinositol (PI) 3-kinase is a key signaling molecule in insulin-stimulated glucose transport. Therefore, we investigated the catalytic subunit p110beta, of human PI 3-kinase as a candidate gene for type 2 diabetes. Human p110beta gene was cloned from the placental genomic library. All 22 exons, intronic regions flanking the exons and 1.5 kb of the proximal/5' region of the p110beta gene, were screened for variants by single-strand conformation polymorphism analysis in 79 Finnish patients with type 2 diabetes . Allele frequencies of the variants were also determined in 77 nondiabetic control subjects. No variants were found in exons in diabetic patients. However, we identified two nucleotide polymorphisms in the proximal/5' region of the p110beta gene and a variation in the number of 2-bp repeat sequence (TA)n in intron 4. The allele frequencies did not differ between diabetic and control subjects. Our results may indicate that the catalytic subunit p110beta of PI 3-kinase plays such a fundamental role in the insulin-signaling pathway that structural variants are not likely to exist in that gene. The importance of the polymorphisms in the proximal/5' region of the p110beta gene for insulin signaling remains to be determined.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Le Stunff, A. Dechartres, V. Mariot, C. Lotton, C. Trainor, E. Miraglia Del Giudice, D. Meyre, I. Bieche, I. Laurendeau, P. Froguel, et al. Association Analysis Indicates That a Variant GATA-Binding Site in the PIK3CB Promoter Is a Cis-Acting Expression Quantitative Trait Locus for This Gene and Attenuates Insulin Resistance in Obese Children Diabetes, February 1, 2008; 57(2): 494 - 502. [Abstract] [Full Text] [PDF]

				M. Bonafe, M. Barbieri, F. Marchegiani, F. Olivieri, E. Ragno, C. Giampieri, E. Mugianesi, M. Centurelli, C. Franceschi, and G. Paolisso Polymorphic Variants of Insulin-Like Growth Factor I (IGF-I) Receptor and Phosphoinositide 3-Kinase Genes Affect IGF-I Plasma Levels and Human Longevity: Cues for an Evolutionarily Conserved Mechanism of Life Span Control J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3299 - 3304. [Abstract] [Full Text] [PDF]

				M. Kossila, J. Pihlajamaki, P. Karkkainen, R. Miettinen, P. Kekalainen, I. Vauhkonen, S. Yla-Herttuala, and M. Laakso Promoter Polymorphisms -359T/C and -303A/G of the Catalytic Subunit p110{beta} Gene of Human Phosphatidylinositol 3-Kinase Are Not Associated With Insulin Secretion or Insulin Sensitivity in Finnish Subjects Diabetes Care, January 1, 2003; 26(1): 179 - 182. [Abstract] [Full Text] [PDF]

				S. E. Nikoulina, T. P. Ciaraldi, L. Carter, S. Mudaliar, K. S. Park, and R. R. Henry Impaired Muscle Glycogen Synthase in Type 2 Diabetes Is Associated with Diminished Phosphatidylinositol 3-Kinase Activation J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4307 - 4314. [Abstract] [Full Text] [PDF]